The COVID-19 patients with lung fibrosis were older and had higher plasma levels of CRP and prevalence of hypertension compared with those without fibrosis (p < 0.001 for CRP; p = 0.008 for the prevalence of hypertension). Here, CRP is linked to pulmonary fibrosis.